Press Releases

OS ANGELES--(BUSINESS WIRE)--Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), announced today that Academy Award, Golden Globe and Emmy Award-winning actor/producer/entrepreneur Nicole Kidman and Sera Labs CEO/CURE Pharmaceutical Chief...

Fiscal Year 2020 Highlights: Generated dramatic growth in total and pro forma revenue Released positive clinical data on its patented drug delivery technology and received new certifications at its research facility Acquired and expanded consumer wellness subsidiary...

OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched a new initiative for the clinical development of psychedelic compounds...

OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs and added new corresponding...

Sleep A.S.A.P. provides proof of concept and monetization for CURE's patented oral thin-film technology LOS ANGELES & OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug...

OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced this week's start of...

OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. After...

Sera Labs Pioneers the Delivery of Next Generation Immune Support in the Continued Battle Against the COVID-19 Pandemic LOS ANGELES & OXNARD, Calif. - According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D...

Health, Wellness, CBD and plant-based anti-aging skincare powerhouse, Sera Labs wins Drug Store News' annual Natural Products Award LOS ANGELES & OXNARD, Calif. - The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical...

OXNARD, Calif. - CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's Chief Executive Officer...

OXNARD, Calif. - CURE Pharmaceutical Holding Corp ("CURE" or the "Company") (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's...

OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S....

OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, today announced that management will present on the company at the LD...

OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today that it has issued a letter to its shareholders...

- Funds will support the branding & product launch of Cure's consumer products by newly acquired Sera Labs and the advancement of CURE's clinical pharmaceutical pipeline - OXNARD, Calif. - CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of...

SeraLabs Challenges the Status Quo of the Health & Wellness Sector with Nutri-Strips for commercialization and monetization with the launch of first product, Sleep A.S.A.P.CURE Pharmaceutical Holding (OTCQB: CURR) wholly owned subsidiary Sera Labs is challenging...

- Acquisition to Support Cash Flow Positive Goal in ~18 Months - OXNARD, Calif. - CURE Pharmaceutical Holdings (OTC: CURR) today announced its definitive agreement to acquire Sera Labs, Inc. The closing is anticipated to occur in early October. As previously...